Literature DB >> 9204295

Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.

R Linder1.   

Abstract

Rhodococcus equi and Arcanobacterium haemolyticum, formerly classified in the genus Corynebacterium, are members of the loosely defined taxon "coryneform" bacteria. Although they are the etiologic agents of distinct human infections, both organisms are frequently overlooked, which results in missed or delayed diagnoses. R. equi, long known as an important pathogen of immature horses, has become in the past three decades an opportunistic pathogen of severely immunosuppressed humans. Most cases are secondary to HIV infection. When specifically sought in throat swab cultures, A. haemolyticum is found responsible for 0.5% to 2.5% of bacterial pharyngitis, especially among adolescents. These two microorganisms represent a spectrum of disease in humans: from a mild, common illness to a rare life-threatening infection. Each organism elaborates lipid hydrolyzing enzymes (cholesterol oxidase by R. equi and sphingomyelinase D by A. haemolyticum) that are toxic to animals and humans and damaging to mammalian cell membranes. The participation of the cytotoxins in pathogenicity is discussed. Greater awareness of the properties of these two bacteria may promote faster, more accurate diagnoses and better clinical management.

Entities:  

Mesh:

Year:  1997        PMID: 9204295      PMCID: PMC2627624          DOI: 10.3201/eid0302.970207

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  35 in total

1.  THE EFFECT ON ANIMAL ERYTHROCYTES OF COMBINATIONS OF DIFFUSIBLE SUBSTANCES PRODUCED BY BACTERIA.

Authors:  G FRASER
Journal:  J Pathol Bacteriol       Date:  1964-07

Review 2.  Rhodococcus equi infection in patients with and without human immunodeficiency virus infection.

Authors:  R L Harvey; J C Sunstrum
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

3.  Humoral immune response to Rhodococcus equi in AIDS patients with R. equi pneumonia.

Authors:  C M Mastroianni; M Lichtner; V Vullo; S Delia
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

4.  Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov.

Authors:  M D Collins; D Jones; G M Schofield
Journal:  J Gen Microbiol       Date:  1982-06

5.  Penicillin-binding proteins of Rhodococcus equi: potential role in resistance to imipenem.

Authors:  P Nordmann; M H Nicolas; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

6.  Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals.

Authors:  S K Hietala; A A Ardans
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

7.  Virulence of Rhodococcus equi isolates from patients with and without AIDS.

Authors:  S Takai; Y Sasaki; T Ikeda; Y Uchida; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

8.  Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.

Authors:  M M McNeil; J M Brown
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Interaction of virulent and non-virulent Rhodococcus equi human isolates with phagocytes, fibroblast- and epithelial-derived cells.

Authors:  P Nordmann; N Zinzendorf; M Keller; I Lair; E Ronco; M Guenounou
Journal:  FEMS Immunol Med Microbiol       Date:  1994-09

10.  Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  14 in total

1.  Cavitary Rhodococcus equi pneumonia with endobronchial granulomas: report of an unusual case.

Authors:  S A Fidvi; A R Brudnicki; M I Chowdhury; D Beneck
Journal:  Pediatr Radiol       Date:  2002-12-10

2.  Arcanobacterium haemolyticum Utilizes Both Phospholipase D and Arcanolysin To Mediate Its Uptake into Nonphagocytic Cells.

Authors:  Patrick S Gellings; David J McGee
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

3.  Detection of antibodies against Rhodococcus equi in Alpaca (Lama pacos) in Italy.

Authors:  V Cuteri; S Takai; M L Marenzoni; M Morgante; C Valente
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin.

Authors:  Yajamana Ramu; Yanping Xu; Zhe Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-30       Impact factor: 11.205

5.  Changpingibacter yushuensis gen. nov., sp. nov., isolated from fluvial sediment in Qinghai Tibet Plateau of China.

Authors:  Yifan Jiao; Sihui Zhang; Jing Yang; Xin-He Lai; Kui Dong; Yanpeng Cheng; Mingchao Xu; Wentao Zhu; Shan Lu; Dong Jin; Ji Pu; Ying Huang; Liyun Liu; Suping Wang; Jianguo Xu
Journal:  J Microbiol       Date:  2022-01-07       Impact factor: 3.422

6.  A hydrogen-bonding network is important for oxidation and isomerization in the reaction catalyzed by cholesterol oxidase.

Authors:  Artem Y Lyubimov; Lin Chen; Nicole S Sampson; Alice Vrielink
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-10-22

7.  Phenotypic and genotypic characterization of Arcanobacterium haemolyticum isolates from infections of horses.

Authors:  Abdulwahed Ahmed Hassan; Hivda Ulbegi-Mohyla; Talah Kanbar; Jörg Alber; Christoph Lämmler; Amir Abdulmawjood; Michael Zschöck; Reinhard Weiss
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

8.  Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum.

Authors:  B Helen Jost; Erynn A Lucas; Stephen J Billington; Adam J Ratner; David J McGee
Journal:  BMC Microbiol       Date:  2011-10-26       Impact factor: 3.605

9.  Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.

Authors:  Jan J Meeuse; Herman G Sprenger; Sander van Assen; Dominique Leduc; Simon M G J Daenen; Jan P Arends; Tjip S van der Werf
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

10.  Lemierre Syndrome Caused by Arcanobacterium haemolyticum Alone in a Healthy Man.

Authors:  Kyoung Jin Lee; Eo Jin Kim; Seung Ji Kang; Mi Ok Jang; Hee-Chang Jang; Sook In Jung; Jong Hee Shin; Kyung Hwa Park
Journal:  Chonnam Med J       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.